Literature DB >> 19453748

Molecular and infection biology of the horse pathogen Rhodococcus equi.

Kristine von Bargen1, Albert Haas.   

Abstract

The soil actinomycete Rhodococcus equi is a pulmonary pathogen of young horses and AIDS patients. As a facultative intracellular bacterium, R. equi survives and multiplies in macrophages and establishes its specific niche inside the host cell. Recent research into chromosomal virulence factors and into the role of virulence plasmids in infection and host tropism has presented novel aspects of R. equi infection biology and pathogenicity. This review will focus on new findings in R. equi biology, the trafficking of R. equi-containing vacuoles inside host cells, factors involved in virulence and host resistance and on host-pathogen interaction on organismal and cellular levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19453748     DOI: 10.1111/j.1574-6976.2009.00181.x

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  42 in total

1.  Study of lysozyme resistance in Rhodococcus equi.

Authors:  Laurent Hébert; Pauline Bidaud; Didier Goux; Abdellah Benachour; Claire Laugier; Sandrine Petry
Journal:  Curr Microbiol       Date:  2013-10-30       Impact factor: 2.188

Review 2.  Pseudotumor of the tracheal-laryngeal junction with unusual morphologic features caused by Rhodococcus equi infection.

Authors:  Shreeram Akilesh; Sara Cross; Katherine Kimmelshue; Nigar Kirmani; Louis P Dehner; Samir K El-Mofty
Journal:  Head Neck Pathol       Date:  2011-04-26

3.  Infectious pseudotumors: red herrings in head and neck pathology.

Authors:  Samir K El-Mofty; Shreeram Akilesh
Journal:  Head Neck Pathol       Date:  2012-03-20

Review 4.  Paternal uniparental isodisomy of chromosome 6 causing a complex syndrome including complete IFN-gamma receptor 1 deficiency.

Authors:  Carolina Prando; Stéphanie Boisson-Dupuis; Audrey V Grant; Xiao-Fei Kong; Jacinta Bustamante; Jacqueline Feinberg; Ariane Chapgier; Yoann Rose; Lucile Jannière; Elena Rizzardi; Qiuping Zhang; Catherine M Shanahan; Louis Viollet; Stanislas Lyonnet; Laurent Abel; Ezia Maria Ruga; Jean-Laurent Casanova
Journal:  Am J Med Genet A       Date:  2010-03       Impact factor: 2.802

5.  Identification of atypical Rhodococcus-like clinical isolates as Dietzia spp. by 16S rRNA gene sequencing.

Authors:  Lilian Pilares; Jesús Agüero; José A Vázquez-Boland; Luis Martínez-Martínez; Jesús Navas
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

6.  Structural definition of trehalose 6-monomycolates and trehalose 6,6'-dimycolates from the pathogen Rhodococcus equi by multiple-stage linear ion-trap mass spectrometry with electrospray ionization.

Authors:  Fong-Fu Hsu; Jens Wohlmann; John Turk; Albert Haas
Journal:  J Am Soc Mass Spectrom       Date:  2011-10-05       Impact factor: 3.109

7.  Characterization of mycolic acids from the pathogen Rhodococcus equi by tandem mass spectrometry with electrospray ionization.

Authors:  Fong-Fu Hsu; Kristina Soehl; John Turk; Albert Haas
Journal:  Anal Biochem       Date:  2010-10-12       Impact factor: 3.365

8.  Unsaturated fatty acids promote the phagocytosis of P. aeruginosa and R. equi by RAW264.7 macrophages.

Authors:  Stephanie Adolph; Herbert Fuhrmann; Julia Schumann
Journal:  Curr Microbiol       Date:  2012-08-18       Impact factor: 2.188

9.  The hydroxamate siderophore rhequichelin is required for virulence of the pathogenic actinomycete Rhodococcus equi.

Authors:  Raúl Miranda-Casoluengo; Garry B Coulson; Aleksandra Miranda-Casoluengo; José A Vázquez-Boland; Mary K Hondalus; Wim G Meijer
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

10.  Rhodococcus equi virulence-associated protein A is required for diversion of phagosome biogenesis but not for cytotoxicity.

Authors:  Kristine von Bargen; Marco Polidori; Ulrike Becken; Gitta Huth; John F Prescott; Albert Haas
Journal:  Infect Immun       Date:  2009-09-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.